Scientists at Johns Hopkins Medicine report they have created a tiny, nanosize container that can slip inside cells and deliver protein-based medicines and gene therapies of any size — even hefty ones attached to the gene-editing tool called CRISPR. If their creation – constructed of a biodegradable polymer — passes more laboratory testing, it could offer a way to efficiently ferry larger medical compounds into specifically selected target cells.
A report on their work appears in the Dec. 6 issue of Science Advances.
“Most medicines spread throughout the body in an indiscriminate way and don’t target a specific cell,” says biomedical engineer Jordan Green, Ph.D., leader of the research team. “Some medicines, such as antibodies, latch on to targets on the cell’s surface receptors, but we don’t have good systems for delivering biological medicines straight to the inside of a cell, which is where therapies would have the best chance at working properly and with fewer side effects.”
Many academic and commercial scientists have long sought better transit systems for therapies, says Green, professor of biomedical engineering, ophthalmology, oncology, neurosurgery, materials science and engineering, and chemical and biomolecular engineering at the Johns Hopkins University School of Medicine, and a member of the Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins.
Some commercially available techniques use stripped down forms of viruses – known for their ability to “infect” cells directly — to deliver therapies, although the noninfectious versions of these delivery systems can unleash an unwanted immune system response. Other therapies aimed at diseased blood cells, for example, are more cumbersome, requiring patients’ blood to be removed, then zapped with an electric current that opens pores in the cell membrane to gain entry.
The nanosize container that Green and his team developed at Johns Hopkins borrows an idea from the properties of viruses, many of which are nearly spherical in shape and carry both negative and positive charges. With a more neutral overall charge, viruses can get close to cells. That’s not the case with many biological medicines, which consist of highly charged, large proteins and nucleic acids that tend to repel off cells.
To overcome this, graduate student Yuan Rui developed a new biodegradable polymer material. Polymer is the general term for a substance made up of many molecules. To make the polymer, Rui strung together — like the branches of a tree — four component molecules that, over time, break down and dissolve in water. The molecules contain both positive and negative charges.
With a balance of positive and negative charges, the molecules push and pull according to their charge and their hydrogen atoms bond with a biological therapy in the vicinity. The result is a nano-structure containing the biological therapy.
The nanosize container’s positive charges interact with the membrane of a cell, and the container is engulfed in a cellular package called an endosome.
Once inside, the nanosize container breaks open the endosome, and the polymers degrade, leaving the medicine to work inside the cell.
To test their invention, Rui made a nanocontainer of a small protein and fed it to mouse kidney cells in culture dishes. She attached a green fluorescent tag to the small protein and saw bright green splashes throughout most of the cells, indicating that the protein was successfully delivered.
Then, Rui packaged a bigger protein: human immunoglobulin, a therapy typically used to strengthen the immune system and a model for antibody therapies. This time, she found that 90% of the kidney cells she treated lit up with the green fluorescent tag attached to the immunoglobulin.
“When nanoparticles enter a cell, they often get sequestered into endosomes, which degrade its contents, but our experiments show the protein packages uniformly spread throughout most of the cells and were not stuck in the endosomes,” says Rui.
For an even greater challenge, Rui created a nanopackage containing a CRISPR-based protein and nucleic acid complex that could turn off a green fluorescence signal or cause the cells to glow red when the CRISPR compound cut part of a cell’s genome. The researchers saw that the gene editing to disable a gene worked in up to 77% of cells grown in the laboratory and to add or repair a gene in about 4% of cells.
“That’s pretty effective considering, with other gene editing systems, you might get the correct gene-cutting result less than 10 percent of the time,” said Rui. CRISPR-based therapies have the potential to make medicines far more precise with their ability to precisely target genetic flaws that contribute to disease. Some CRISPR therapies are being tested in clinical trials.
In a final experiment, Rui and her colleagues implanted brain cancer cells into the brains of mice. She injected the nanocontainers with gene editing components directly into the mouse brains and analyzed their cells for a red glow indicating successful gene editing. She found brain cancer cells that glowed red several millimeters away from where she injected them.
‘When I first started this project five years ago, scientists didn’t think that you could use something other than a virus to deliver these therapies into cells,” says Rui. “Developing new technologies can help us understand more about disease, but also more about making new drugs.”
Rui and Green are trying to make the nanocontainers more stable so they can be injected into the bloodstream and targeted to cells with certain genetic signatures.
Go deeper with Bing News on:
Nanoscale medicine delivery
- Shining a light on nanoscale dynamicson November 23, 2020 at 4:00 pm
These materials achieve their extraordinary properties through sophisticated structuring at the nanoscale, i.e. through a grid-like arrangement of smallest building blocks on length scales well ...
- Realizing the Biological and Biomedical Potential of Nanoscale Imaging Using a Pipette Probeon November 23, 2020 at 4:00 pm
Department of Cardiac Medicine, Imperial College London, London SW3 6LY, UK Ion conductance microscopy can scan complex cellular structures and tissues with nanoscale resolution. A suite of ...
- New nanotechology design provides hope for personalized ‘vaccination’ to treat canceron November 23, 2020 at 10:08 am
In a collaboration between the Lin Group in the University of Chicago Department of Chemistry and the Weichselbaum Lab at University of Chicago Medicine, the research ... They leveraged the unique ...
- Little things make big things happenon November 18, 2020 at 11:30 am
Emerging understanding of exosomes, nanoscale membrane–bound vesicles released by cells ... acidic environment of the injured myocardium to achieve focal exosome delivery and uptake. After ...
- Researchers apply nanoscale graphene 'magic' angle to acousticson November 18, 2020 at 8:44 am
In a simulation, the research team built the acoustic design from a flat plate containing a hexagonal pattern of holes analogous to the arrangement of atoms in graphene at the nanoscale.
Go deeper with Google Headlines on:
Nanoscale medicine delivery
Go deeper with Bing News on:
- Gene Therapies: What to Knowon November 25, 2020 at 7:51 am
David Israel was diagnosed with lymphoma in 2015, the start of a two-year gauntlet of treatments including chemotherapy and a stem cell transplant. The cancer kept winning, and in the summer of 2017, ...
- Future Visioning the Role of CRISPR Gene Editing: Navigating Law and Ethics to Regenerate Health and Cure Diseaseon November 24, 2020 at 9:16 am
CRISPR/Cas9 gene editing promises to enable the engineering of genomes of cell-based therapies and make them safer and available to a broader group of patients. Cell therapies have already begun ...
- ChristianaCare Gene Editing Institute gets $1M grant to advance CRISPR workon November 24, 2020 at 2:42 am
The therapy involves the use of CRISPR, an acronym for "clustered regularly interspaced short palindromic repeats." The gene-editing technique allows researchers to alter DNA sequences and modify ...
- CRISPR-Based Therapy Shows Early Promise for Canceron November 23, 2020 at 1:56 pm
Researchers say they have used CRISPR, a new technology that allows scientists to edit a cell’s DNA, to destroy cancer cells in mice.
- Researchers tackle sickle cell disease with CRISPR-based gene editingon November 23, 2020 at 5:20 am
including the development of the first CRISPR gene editing tool to allow DNA repairs outside the human cell that will rapidly speed therapies to patients and a unique version of CRISPR called ...